Fringe Science
Practice this intermediate profitability case interview question in the Healthcare sector. Includes detailed problem prompt, clarifying questions, structured framework, and expert recommendation. Part of ProHub's 835+ consulting case library.
This is a sophisticated healthcare profitability case requiring candidates to integrate multiple quantitative and qualitative factors. The case tests market sizing, probability-weighted financial analysis, and strategic pricing decisions while incorporating healthcare-specific considerations like formulary status and clinical efficacy profiles. An excellent candidate must proactively identify the need for additional data, perform expected value calculations, and recognize that higher prices trade off against market access in healthcare markets.
Clarifying Information
- Drug is only likely to be approved in the US at this time
- Drug will be sold directly to hospitals by Massive Dynamic; therefore, no need to consider distribution channel costs, etc.
- No need to calculate based on NPV, just do total over five years w/out discounting
- Provide Exhibit 1 when asked about market size and/or competition
- Provide Exhibit 2 when asked about development costs or clinical profile
- Provide Exhibit 3 after an initial indication selected and pricing prompt given